Sources | Names Used |
---|---|
CTRPv2 | doxorubicin:navitoclax (2:1 mol/mol) |
PharmacoGx | doxorubicin:navitoclax (2:1 mol/mol) |
Feature Type | Standardized | Nominal ANOVA | ||||
---|---|---|---|---|---|---|
mRNA | HNRNPU | CTRPv2 | pan-cancer | AAC | 0.22 | 1e-10 |
mRNA | SAFB | CTRPv2 | pan-cancer | AAC | 0.24 | 1e-10 |
mRNA | CDK19 | CTRPv2 | pan-cancer | AAC | 0.22 | 1e-10 |
mRNA | SBK1 | CTRPv2 | pan-cancer | AAC | 0.22 | 1e-10 |
mRNA | RNF181 | CTRPv2 | pan-cancer | AAC | -0.21 | 1e-10 |
mRNA | SLFN11 | CTRPv2 | pan-cancer | AAC | 0.22 | 1e-10 |
mRNA | CNIH2 | CTRPv2 | pan-cancer | AAC | 0.22 | 2e-10 |
mRNA | H3F3A | CTRPv2 | pan-cancer | AAC | 0.22 | 2e-10 |
mRNA | TMPO | CTRPv2 | pan-cancer | AAC | 0.22 | 2e-10 |
mRNA | ZNF713 | CTRPv2 | pan-cancer | AAC | 0.21 | 2e-10 |